![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
Title
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
Phase ![sort descending](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/arrow_down.gif)
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
Protocol IDs
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
Phase III, Phase II
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
RPCI-RP-9815
NCI-V99-1527, NCT00003816, RP 98-15
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
Phase III, Phase II
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
GC P#02.01.001
NCT00469729
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
In-Vivo Activated T-Cell Depletion to Prevent GVHD
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
Phase III, Phase II
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
0705-20 IUCRO-0196
NCT00594308
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
Chemotherapy With or Without Total-Body Irradiation in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Myelodysplastic Syndromes or Acute Myeloid Leukemia
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
FHCRC-1992.00
6170, NCT00322101, NHLBI-K23-HL084054-01A1
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
418
BMTCTN-0201, NCT00075816
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
SCT 0307
NCT00619879
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD)
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
385
BMT CTN 0402, U01 HL069294-05, NCT00406393
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
Chemotherapy Followed by Allogeneic Stem Cell Transplantation in Treating Children With Hematologic Cancer
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
Phase II, Phase I
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
NCI-01-C-0125F
NCT00020592
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
Donor Peripheral Stem Cell Transplant in Treating Patients With
Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative
Disorder
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
Phase II, Phase I
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
FHCRC-1628.00
NCI-H02-0099, NCT00049634
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Allogeneic Transplantation
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
Phase II, Phase I
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
FHCRC-1803.00
5606, NCT00068718
![](https://webarchive.library.unt.edu/eot2008/20081022165649im_/http://www.cancer.gov/images/spacer.gif)
|
|